The Optimal Dose of Tacrolimus in Combination Therapy with an Anti-TNFα Antibody in a Mouse Colitis Model-Reference-Cited by-同舟云学术

The Optimal Dose of Tacrolimus in Combination Therapy with an Anti-TNFα Antibody in a Mouse Colitis Model

Published:2021-04-01 Issue:4 Volume:44 Page:564-570
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Murakami Yuki¹,Fujiya Mikihiro¹²,Konishi Hiroaki²,Isozaki Shotaro¹,Sugiyama Yuya¹,Kobayashi Yu¹,Sasaki Takahiro¹,Kunogi Takehito¹,Takahashi Keitaro¹,Ando Katsuyoshi¹,Ueno Nobuhiro¹,Kashima Shin¹,Moriichi Kentaro¹,Tanabe Hiroki¹,Okumura Toshikatsu¹

Affiliation:

1. Division of Gastroenterology and Hematology/Oncology, Department of Medicine, Asahikawa Medical University

2. Department of Gastroenterology and Advanced Medical Sciences, Asahikawa Medical University

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/44/4/44_b20-00916/_pdf

Reference24 articles.

1. 1) Khan N, Abbas A, Williamson A, Balart L. Prevalence of corticosteroids use and disease course after initial steroid exposure in ulcerative colitis. Dig. Dis. Sci., 58, 2963–2969 (2013).

2. 2) Rutgeerts P, Sandborn WJ, Feagan BG, Reinisch W, Olson A, Johanns J, Travers S, Rachmilewitz D, Hanauer SB, Lichtenstein GR, de Villiers WJ, Present D, Sands BE, Colombel JF. Infliximab for induction and maintenance therapy for ulcerative colitis. N. Engl. J. Med., 353, 2462–2476 (2005).

3. 3) Ogata H, Matsui T, Nakamura M, Iida M, Takazoe M, Suzuki Y, Hibi T. A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis. Gut, 55, 1255–1262 (2006).

4. 4) Ogata H, Kato J, Hirai F, Hida N, Matsui T, Matsumoto T, Koyanagi K, Hibi T. Double-blind, placebo-controlled trial of oral tacrolimus (FK506) in the management of hospitalized patients with steroid-refractory ulcerative colitis. Inflamm. Bowel Dis., 18, 803–808 (2012).

5. 5) Boschetti G, Nancey S, Moussata D, Stefanescu C, Roblin X, Chauvenet M, Stroeymeyt K, Bouhnik Y, Flourie B. Tacrolimus induction followed by maintenance monotherapy is useful in selected patients with moderate-to-severe ulcerative colitis refractory to prior treatment. Dig. Liver Dis., 46, 875–880 (2014).

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TNF-α Mediated the Disruption of Hepatic Tight Junction Expression in Blood–Biliary Barrier of Colitis <i>via</i> Downregulating PI3K/AKT Signaling Pathway;Biological and Pharmaceutical Bulletin;2023-12-01

2. Two new lignans with their biological activities in L;Phytochemistry Letters;2022-08

3. A new alkaloid and two organic acids from Portulaca oleracea L. and their bioactivities;Natural Product Research;2022-07-23